Lifecore Biomedical Inc (LFCR)
7.31
+0.33
(+4.73%)
USD |
NASDAQ |
Nov 22, 16:00
7.29
-0.02
(-0.27%)
After-Hours: 20:00
Lifecore Biomedical Research and Development Expense (Quarterly): 2.186M for Aug. 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 2.186M |
| May 31, 2024 | 2.161M |
| February 29, 2024 | 2.17M |
| November 30, 2023 | 2.098M |
| August 31, 2023 | 2.146M |
| May 31, 2023 | 2.115M |
| February 28, 2023 | 2.234M |
| November 30, 2022 | 2.177M |
| August 31, 2022 | 2.211M |
| May 31, 2022 | 2.117M |
| February 28, 2022 | 2.00M |
| November 30, 2021 | 1.856M |
| August 31, 2021 | 1.873M |
| May 31, 2021 | 1.161M |
| February 28, 2021 | 1.843M |
| November 30, 2020 | 2.572M |
| August 31, 2020 | 2.508M |
| May 31, 2020 | -0.808M |
| February 29, 2020 | 2.747M |
| November 30, 2019 | 2.822M |
| August 31, 2019 | 2.821M |
| May 31, 2019 | 3.461M |
| February 28, 2019 | 2.739M |
| November 30, 2018 | 2.475M |
| August 31, 2018 | 2.791M |
| Date | Value |
|---|---|
| May 31, 2018 | 3.596M |
| February 28, 2018 | 3.113M |
| November 30, 2017 | 3.372M |
| August 31, 2017 | 2.719M |
| May 31, 2017 | 3.556M |
| February 28, 2017 | 2.014M |
| November 30, 2016 | 1.965M |
| August 31, 2016 | 1.938M |
| May 31, 2016 | 1.815M |
| February 29, 2016 | 1.895M |
| November 30, 2015 | 1.643M |
| August 31, 2015 | 1.875M |
| May 31, 2015 | 1.613M |
| February 28, 2015 | 1.755M |
| November 30, 2014 | 1.825M |
| August 31, 2014 | 1.795M |
| May 31, 2014 | 1.636M |
| February 28, 2014 | 1.723M |
| November 30, 2013 | 1.919M |
| August 31, 2013 | 1.926M |
| May 31, 2013 | 2.652M |
| February 28, 2013 | 2.325M |
| November 30, 2012 | 2.113M |
| August 31, 2012 | 2.204M |
| May 31, 2012 | 2.483M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
-0.808M
Minimum
May 2020
2.822M
Maximum
Nov 2019
2.010M
Average
2.154M
Median
Research and Development Expense (Quarterly) Benchmarks
| AngioDynamics Inc | 6.285M |
| Precision Optics Corp Inc | 0.4007M |
| Sage Therapeutics Inc | 54.58M |
| Outset Medical Inc | 8.139M |
| NovaBay Pharmaceuticals Inc | 0.004M |